---
figid: PMC7303042__gr1_lrg
figtitle: Targeting the adenosinergic pathway components by using anti-CD73, anti-CD39
  monoclonal antibodies and A2AR receptor antagonist
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Influenza A virus
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Homo sapiens
- Canis lupus familiaris
- Staphylococcus pseudintermedius
pmcid: PMC7303042
filename: gr1_lrg.jpg
figlink: pmc/articles/PMC7303042/figure/f0005/
number: F1
caption: Targeting the adenosinergic pathway components by using anti-CD73, anti-CD39
  monoclonal antibodies and A2AR receptor antagonist.
papertitle: 'Targeting adenosinergic pathway and adenosine A2A receptor signaling
  for the treatment of COVID-19: A hypothesis.'
reftext: Mohamed A. Abouelkhair. Med Hypotheses. 2020 Nov;144:110012-110012.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8899379
figid_alias: PMC7303042__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC7303042__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7303042__gr1_lrg.html
  '@type': Dataset
  description: Targeting the adenosinergic pathway components by using anti-CD73,
    anti-CD39 monoclonal antibodies and A2AR receptor antagonist.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP
  - ADP
  - AMP
  - AzA
  - inflammation
---
